Agilent Wins Shot At Keeping Tablet Testing Patent At EPO
Agilent has revived its hopes of retaining protections over a pharmaceutical tablet testing device in Europe after convincing an appeals panel that it did not unlawfully broaden the patent with its...To view the full article, register now.
Already a subscriber? Click here to view full article